01—Abstract
Summary
Summary of the 10-Q filed May 6, 2025. Cited figures are marked; the original filing is the authoritative source.
Leidos Holdings, Inc. reported first-quarter fiscal 2025 results for the three months ended April 4, 2025.
Revenues rose to $4,245 milliona from $3,975 million, a 6.8% increase. Operating income grew to $530 million from $415 million, a 27.7% increase, and operating margin improved to 12.5% from 10.4%. Net income attributable to Leidos common stockholders was $363 million versus $284 million, and diluted EPS was $2.77 compared with $2.07.
The filing attributes segment gains mainly to higher volumes and program wins. Health & Civil operating income rose 34.7%, and Defense Systems operating income rose 61.9%. The company recorded net contract estimate changes that favorably affected income before taxes by $30 millionb, or $0.17 of diluted EPS.
Cash flow and capital allocation shifted during the quarter. Net cash from operations was $58 millionc, down from $113 million, mainly due to the timing of payroll and employee benefit payments. In February 2025, Leidos issued $1.0 billion of senior notes due 2032 and 2035 and used the proceeds to retire $500 million of notes due May 2025 and fund a $500 million accelerated share repurchase.
Total debt was $5.1 billiond at April 4, 2025, up from $4.7 billion, and cash and cash equivalents were $842 million. The $1.0 billion revolving facility was undrawn, and the company was in compliance with its financial covenants. Backlog totaled $46,296 million, up from $41,683 million in the prior-year period, which the company recast to include estimated sole-source IDIQ task orders.
Net bookings were $2.1 billion, compared with $3.8 billion a year earlier. Remaining performance obligations were $17 billion. The company also signed a definitive agreement on March 10, 2025 to acquire a cyber company for a preliminary price of $300 million, with closing expected in the second quarter of 2025.
Government exposure remains high: about 87% of revenues came from U.S. government contracts, and the filing notes that the Department of Government Efficiency has led to contract cancellations, modifications and stop-work orders. The company also disclosed an ongoing SEC inquiry and a Department of Justice Antitrust Division grand jury investigation, and it said it cannot currently estimate any resulting fines or liabilities.
02—Key points
Key Highlights
- Revenues of $4,245 million, up 6.8% from $3,975 million, with operating income of $530 million, up 27.7%, and operating margin of 12.5% versus 10.4%.
- Net income attributable to Leidos common stockholders of $363 million ($2.77 diluted EPS) versus $284 million ($2.07) in the prior-year quarter.
- Backlog of $46,296 million (recast to include sole-source IDIQ task orders) and net bookings of $2.1 billion, down from $3.8 billion a year earlier; remaining performance obligations of $17 billion.
- Operating cash flow fell to $58 million from $113 million, mainly due to timing of payroll and employee benefit payments.
- Issued $1.0 billion of senior notes in February 2025, retired $500 million of notes due May 2025, and completed a $500 million accelerated share repurchase; total debt rose to $5.1 billion.
- Agreed on March 10, 2025 to acquire a cyber company for a preliminary price of $300 million, expected to close in the second quarter of 2025.
- Approximately 87% of revenues came from U.S. government contracts, and the filing cites contract cancellations, modifications and stop-work orders tied to the Department of Government Efficiency.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2026, Leidos Holdings kept $0.09.
- Revenue$4.23B100.0%
- Cost of revenue−$3.49B82.5%
- Gross profit$740.0M17.5%
- Operating costs−$210.0M5.0%
- Operating income$530.0M12.5%
- Interest, other & tax−$167.0M3.9%
- Net income$363.0M8.6%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2026filed May 6, 2025Financial Statements
Q1 FY2026 against Q1 FY2025
| Line item | Q1 FY2026Q1 FY2025 | Change |
|---|---|---|
| Revenue | $4.23B$3.95B | +7.0% |
| Cost of Revenue | $3.49B$3.34B | +4.5% |
| Gross Profit | $740.00M$614.00M | +20.5% |
| SG&A Expenses | $230.00M$226.00M | +1.8% |
| Operating Income | $530.00M$415.00M | +27.7% |
| Net Income | $363.00M$284.00M | +27.8% |
| EPS (Basic) | $2.79$2.09 | +33.5% |
| EPS (Diluted) | $2.77$2.07 | +33.8% |
| Shares Outstanding (Basic) | 130.00M136.00M | −4.4% |
| Shares Outstanding (Diluted) | 131.00M137.00M | −4.4% |
05—Questions
Frequently Asked Questions
What drove the improvement in operating income this quarter?
Operating income rose to $530 million from $415 million. The filing attributes segment gains mainly to net increases in volumes and program wins. Health & Civil operating income rose to $299 million from $222 million on higher volumes and case complexity in managed health services, and Defense Systems operating income rose to $34 million from $21 million due to program wins and lower amortization expense. Corporate operating loss narrowed to $25 million from $37 million.
How is Leidos funding its debt and share repurchases, and what is its liquidity position?
In February 2025 Leidos issued $500 million of 5.40% notes due 2032 and $500 million of 5.50% notes due 2035. Proceeds retired the $500 million notes due May 2025 and funded a $500 million accelerated share repurchase, which delivered an initial 3 million shares at an average $131.50. At April 4, 2025 the company held $842 million of cash and cash equivalents and a $1.0 billion revolving facility with no borrowings outstanding. It also has a $1.0 billion commercial paper program with no notes outstanding. Management said it expects to meet liquidity needs for the next 12 months.
What are the main risks tied to government spending and investigations?</br>
About 87% of revenues came from U.S. government contracts, so results depend on government spending priorities. The filing notes that the current continuing resolution runs through September 30, 2025 and that Department of Government Efficiency initiatives have led to contract cancellations, modifications and stop-work orders. Leidos also disclosed that it self-reported an international operations investigation to the DOJ and SEC; the DOJ closed its inquiry in December 2024, but the SEC matter's timing and outcome cannot be anticipated. A DOJ Antitrust Division grand jury subpoena from August 2022 relates to three procurements, and the company cannot currently estimate any resulting fines or liabilities.
How did cash flow and working capital change in the quarter?
Net cash provided by operating activities was $58 million versus $113 million in the prior-year quarter, a decrease the filing attributes primarily to the timing of payroll and employee benefit payments, partly offset by higher earnings and favorable working capital changes. Receivables increased by $246 million in cash-flow terms, and accrued payroll and employee benefits decreased by $148 million. Capital expenditures were $22 million, and dividends paid were $53 million.
What is the pending acquisition and what does the backlog change indicate?
On March 10, 2025 Leidos agreed to acquire a full-spectrum cyber company that develops offensive and defensive cyber platforms for the U.S. Government, for a preliminary purchase price of $300 million, subject to adjustments. Closing is expected in the second quarter of 2025. Total backlog was $46,296 million, compared with $41,683 million a year earlier as recast; the company changed its policy to include estimated sole-source IDIQ task orders, which added $5,112 million to unfunded backlog in the prior-year recast. Net bookings were $2.1 billion versus $3.8 billion.
06—Continue